Kedrion collects and fractionates blood plasma to create plasma derivatives used in the treatment of conditions such as hemophilia and immune system deficiencies. With a market presence in 100 countries, the company has plants in Italy, Hungary, and the United States, as well as plasma collection centers in the US. Kedrion aims to build a diverse and professional workforce, offering job opportunities for both external candidates and internal employees. Their plasma-derived therapies help people suffering from debilitating conditions, providing hope and improving their quality of life.